New collagen injection aims to smooth wrinkles and plump skin
NCT ID NCT07413445
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early trial tests an injectable collagen-based product called MEC REGENERATE® in 20 adults aged 35–65 with skin laxity, mid-face volume loss, or wrinkles. Participants receive a single injection session, and researchers check safety and skin hydration after 60 days. The goal is to see if the product is safe and may improve skin appearance.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Injectable recombinant collagen-based product
What this could lead to
If it works, this could point toward a non-surgical option to temporarily improve skin hydration and reduce wrinkles.
What could go wrong
This is a very small, early study with only 20 people and no control group. Results may not apply to the general population, and long-term safety or effectiveness is unknown.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LAXITY; SKIN are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Ospedale Policlinico San Martino, Istituto di Ricovero e Cura a Carattere Scientifico
Genova, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••